<?xml version="1.0" encoding="UTF-8"?>
<p>Other trials have been performed with high (higher than the previous ones) doses of pure EPA. In this respect, the small, i.e., 193 patients, and non-blinded Japanese CHERRY (combination therapy of eicosapentaenoic acid and pitavastatin (PTV) for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography) study, which used intravascular ultrasound, reported that combination EPA (1.800 gr/d)/PTV therapy significantly reduced coronary plaque volume compared to PTV therapy alone [
 <xref rid="B91-nutrients-12-03782" ref-type="bibr">91</xref>].
</p>
